$151 Million is the total value of Blue Water Life Science Advisors, LP's 8 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 25.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NTRA | NATERA INC | $48,937,327 | +38.2% | 881,436 | 0.0% | 32.36% | +36.0% | |
ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $26,758,732 | +15.6% | 3,030,434 | 0.0% | 17.69% | +13.8% | |
AKYA | Buy | AKOYA BIOSCIENCES INC | $17,159,881 | -3.0% | 2,097,785 | +13.5% | 11.35% | -4.5% |
MAXCYTE INC | $15,963,750 | -9.3% | 3,225,000 | 0.0% | 10.56% | -10.8% | ||
GH | Sell | GUARDANT HEALTH INC | $11,496,031 | -51.3% | 490,445 | -43.5% | 7.60% | -52.1% |
BRKR | New | BRUKER CORP | $11,439,684 | – | 145,100 | +100.0% | 7.56% | – |
Sell | CYTEK BIOSCIENCES INC | $10,191,710 | -23.2% | 1,109,000 | -14.7% | 6.74% | -24.4% | |
SONENDO INC | $9,286,922 | -29.3% | 4,643,461 | 0.0% | 6.14% | -30.4% | ||
DHR | Exit | DANAHER CORPORATION | $0 | – | -18,750 | -100.0% | -3.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NATERA INC | 12 | Q3 2023 | 33.3% |
GUARDANT HEALTH INC | 12 | Q3 2023 | 21.3% |
AKOYA BIOSCIENCES INC | 8 | Q3 2023 | 23.4% |
ADAPTIVE BIOTECHNOLOGIES COR | 8 | Q3 2023 | 17.7% |
CAREDX INC | 7 | Q2 2022 | 19.0% |
THERMO FISHER SCIENTIFIC INC | 5 | Q4 2021 | 16.0% |
MAXCYTE INC | 5 | Q3 2023 | 11.8% |
BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-18 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.